Biologic therapies targeting type 2 inflammation in NSAID-exacerbated respiratory disease. [PDF]
Szatkowski P +3 more
europepmc +1 more source
Alpha7 nicotinic acetylcholine receptor activation attenuates allergic airway inflammation and is associated with heme oxygenase-1 induction. [PDF]
Iriki J +13 more
europepmc +1 more source
Mapping structural-immune crosstalk in asthma. [PDF]
Chen L, Jin YX, Sun JL.
europepmc +1 more source
Tezepelumab in severe asthma with pulmonary mucus plugs and eosinophilic chronic rhinosinusitis after dupilumab intolerance and suboptimal mepolizumab response: A case report. [PDF]
Senoo S +11 more
europepmc +1 more source
The Pleiotropic IL-9 Network in Asthma Pathogenesis and Targeted Therapy. [PDF]
Zhao W, He R, Huang Y, Tu J, Wang X.
europepmc +1 more source
Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies. [PDF]
Schmidt E, Puga MF, Kim BS, Simpson EL.
europepmc +1 more source
Reticular Basement Membrane Remodelling Regulates Bronchial Epithelial Attachment, Barrier Integrity and Inflammatory Signalling in Asthma. [PDF]
Hsieh A +4 more
europepmc +1 more source
Biologic therapies targeting type 2 inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomised controlled trials. [PDF]
Pescaru C +6 more
europepmc +1 more source
Biological treatments for asthma and chronic obstructive pulmonary disease. [PDF]
Tejwani V +4 more
europepmc +1 more source
Predictive value of bronchoalveolar lavage fluid interleukin-25, interleukin-33, and thymic stromal lymphopoietin levels for asthma development in children with recurrent wheezing. [PDF]
Zhao Y, Ling Y, Fu Z, Zou W.
europepmc +1 more source

